{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "SARS-CoV-2", "anti-inflammatory", "antioxidant", "cytokine storm", "immune response", "microbiome", "ozone therapy"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35531273", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "04", "Day": "21"}], "ELocationID": ["871645", "10.3389/fmicb.2022.871645"], "Journal": {"ISSN": "1664-302X", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in microbiology", "ISOAbbreviation": "Front Microbiol"}, "ArticleTitle": "Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2.", "Pagination": {"StartPage": "871645", "MedlinePgn": "871645"}, "Abstract": {"AbstractText": ["Medical oxygen-ozone (O<sub>2</sub>-O<sub>3</sub>) is a successful therapeutic approach accounting on the assessed beneficial action of ozone in the range 30-45\u2009\u03bcg/ml (expanded range 10-80\u2009\u03bcg/ml according to different protocols), as in this dosage range ozone is able to trigger a cellular hormetic response <i>via</i> the modulating activity of reactive oxygen species (ROS), as signaling molecules. The ozone-dependent ROS-mediated fatty acid oxidation leads to the formation of lipid ozonization products (LOPs), which act as signal transducers by triggering ROS signaling and therefore mitohormetic processes. These processes ultimately activate survival mechanisms at a cellular level, such as the Nrf2/Keap1/ARE system activation, the AMPK/FOXO/mTOR/Sir1 pathway and the Nrf2/NF-kB cross talk. Furthermore, indirectly, <i>via</i> these pathways, LOPs trigger the HIF-1\u03b1 pathway, the HO-1 signaling and the NO/iNOS biochemical machinery. Ozone-driven shift of cytokine activation pathways, from pro-inflammatory to anti-inflammatory immediately afterwards, also exert direct immunoregulatory effects on regulatory T lymphocytes as well as on the intestinal microbiota, which in turn can affect immune response thus influencing the progression of the disease. In this review, we will describe the biological and biochemical mechanisms of action of ozone therapy with the aim of evaluating both positive and critical aspects of ozone use as a therapeutic adjuvant in the light of emerging viral infections, such as SARS-CoV-2 and microbiome-associated disorders related to SARS-CoV-2."], "CopyrightInformation": "Copyright \u00a9 2022 Cenci, Macchia, La Sorsa, Sbarigia, Di Donna and Pietraforte."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Core Facilities, Italian National Institute of Health, Rome, Italy."}], "LastName": "Cenci", "ForeName": "Alessandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology and Molecular Medicine, Italian National Institute of Health, Rome, Italy."}], "LastName": "Macchia", "ForeName": "Iole", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Coordination and Support Service, Italian National Institute of Health, Rome, Italy."}], "LastName": "La Sorsa", "ForeName": "Valentina", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "APS S.p.a., Rome, Italy."}], "LastName": "Sbarigia", "ForeName": "Clemente", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Rehabilitation Unit, IRCCS INRCA, Fermo, Italy."}], "LastName": "Di Donna", "ForeName": "Valentina", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Core Facilities, Italian National Institute of Health, Rome, Italy."}], "LastName": "Pietraforte", "ForeName": "Donatella", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Microbiol", "NlmUniqueID": "101548977", "ISSNLinking": "1664-302X"}, "CoiStatement": "CS is employed by APS S.p.a. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "\u00c5kerstr\u00f6m S., Gunalan V., Keng C. T., Keng C. T., Tan Y.-J., Mirazimi A. (2009). Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology 395, 1\u20139. doi: 10.1016/j.virol.2009.09.007, PMID:", "ArticleIdList": ["10.1016/j.virol.2009.09.007", "PMC7111989", "19800091"]}, {"Citation": "Albert S., Amarilla A. A., Trollope B., Sng J., Setoh Y. X., Deering N., et al. . (2021). Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2. Environ. Res. 196:110944. doi: 10.1016/j.envres.2021.110944, PMID:", "ArticleIdList": ["10.1016/j.envres.2021.110944", "PMC7908847", "33647300"]}, {"Citation": "Amor S., Fern\u00e1ndez Blanco L., Baker D. (2020). Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage. Clin. Exp. Immunol. 202, 193\u2013209. doi: 10.1111/cei.13523, PMID:", "ArticleIdList": ["10.1111/cei.13523", "PMC7537271", "32978971"]}, {"Citation": "Araimo F., Imperiale C., Tordiglione P., Ceccarelli G., Borrazzo C., Alessandri F. (2021). Ozone as adjuvant support in the treatment of COVID-19: a preliminary report of probiozovid trial. J. Med. Virol. 93, 2210\u20132220. doi: 10.1002/jmv.26636, PMID:", "ArticleIdList": ["10.1002/jmv.26636", "33111980"]}, {"Citation": "Ataei-Pirkooh A., Alavi A., Kianirad M., Bagherzadeh K., Ghasempour A., Pourdakan O., et al. . (2021). Destruction mechanisms of ozone over SARS-CoV-2. Sci. Rep. 11:18851. doi: 10.1038/s41598-021-97860-w, PMID:", "ArticleIdList": ["10.1038/s41598-021-97860-w", "PMC8458291", "34552128"]}, {"Citation": "Babior B. M., Takeuchi C., Ruedi J., Gutierrez A., Wentworth P., Jr. (2003). Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. U. S. A. 100, 3031\u20133034. doi: 10.1073/pnas.0530251100, PMID:", "ArticleIdList": ["10.1073/pnas.0530251100", "PMC152239", "12601145"]}, {"Citation": "Barbarisi M., Iaffaioli R. V., Armenia E., Schiavo L., De Sena G., Tafuto S., et al. . (2018). Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme. J. Cell. Physiol. 233, 6550\u20136564. doi: 10.1002/jcp.26238, PMID:", "ArticleIdList": ["10.1002/jcp.26238", "29030990"]}, {"Citation": "B\u00e1rcena C., Mayoral P., Quir\u00f3s P. M. (2018). Mitohormesis, an antiaging paradigm. Int. Rev. Cell Mol. Biol. 340, 35\u201377. doi: 10.1016/bs.ircmb.2018.05.002, PMID:", "ArticleIdList": ["10.1016/bs.ircmb.2018.05.002", "30072093"]}, {"Citation": "Barko P. C., McMichael M. A., Swanson K. S., Williams D. A. (2018). The gastrointestinal microbiome: a review. J. Vet. Intern. Med. 32, 9\u201325. doi: 10.1111/jvim.14875", "ArticleIdList": ["10.1111/jvim.14875", "PMC5787212", "29171095"]}, {"Citation": "Bassis C. M., Erb-Downward J. R., Dickson R. P., Freeman C. M., Schmidt T. M., Young V. B., et al. . (2015). Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio 6:e00037. doi: 10.1128/mBio.00037-15, PMID:", "ArticleIdList": ["10.1128/mBio.00037-15", "PMC4358017", "25736890"]}, {"Citation": "Battino R., Rettich T. R., Tominaga T. (1983). The solubility of oxygen and ozone in liquids. J. Phys. Chem. Ref. Data 12, 163\u2013178. doi: 10.1063/1.555680", "ArticleIdList": ["10.1063/1.555680"]}, {"Citation": "Bienert G. P., Schjoerring J. K., Jahn T. P. (2006). Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta 1758, 994\u20131003. doi: 10.1016/j.bbamem.2006.02.015", "ArticleIdList": ["10.1016/j.bbamem.2006.02.015", "16566894"]}, {"Citation": "Bocci V. (1996). Does ozone therapy normalize the cellular redox balance? Implications for the therapy of human immunodeficiency virus infection and several other diseases. Med. Hypotheses 46, 150\u2013154. doi: 10.1016/s0306-9877(96)90016-x, PMID:", "ArticleIdList": ["10.1016/s0306-9877(96)90016-x", "8692040"]}, {"Citation": "Bocci V. (2006a). Is it true that ozone is always toxic? The end of a dogma. Toxicol. Appl. Pharmacol. 216, 493\u2013504. doi: 10.1016/j.taap.2006.06.009, PMID:", "ArticleIdList": ["10.1016/j.taap.2006.06.009", "16890971"]}, {"Citation": "Bocci V. A. (2006b). Scientific and medical aspects of ozone therapy. State of the art. Arch. Med. Res. 37, 425\u2013435. doi: 10.1016/j.arcmed.2005.08.006, PMID:", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Bocci V. (2011). Ozone: A New Medical Drug. 2nd ed.; Springer: Dordrecht, The Netherlands."}, {"Citation": "Bocci V., Aldinucci C., Borrelli E., Corradeschi F., Diadori A., Faneschi G., et al. . (2001). Ozone in medicine. J. Int. Ozone Ass. 23, 207\u2013217. doi: 10.1080/01919510108962004", "ArticleIdList": ["10.1080/01919510108962004"]}, {"Citation": "Bocci V., Valacchi G., Rossi R., Giustarini D., Paccagnini E., Pucci A. M., et al. . (1999). Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 10, 110\u2013116. doi: 10.1080/09537109976167", "ArticleIdList": ["10.1080/09537109976167", "16801079"]}, {"Citation": "Bocci V., Zanardi I., Michaeli D., Travagli V. (2009). Mechanisms of action and chemical-biological interactions between ozone and body compartments: a critical appraisal of the different administration routes. Curr. Drug Ther. 4, 159\u2013173. doi: 10.2174/157488509789055045", "ArticleIdList": ["10.2174/157488509789055045"]}, {"Citation": "Bocci V., Zanardi I., Travagli V. (2010). Ozonation of human HIV-infected plasmas for producing a global vaccine-how HIV-patients may help fight the HIV pandemia. Virulence 1, 215\u2013217. doi: 10.4161/viru.1.3.11830, PMID:", "ArticleIdList": ["10.4161/viru.1.3.11830", "21178445"]}, {"Citation": "Bocci V. A., Zanardi I., Travagli V. (2011). Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 9:66. doi: 10.1186/1479-5876-9-66, PMID:", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Boisson B., Wang C., Pedergnana V., Wu L., Cypowyj S., Rybojad M., et al. . (2013). An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39, 676\u2013686. doi: 10.1016/j.immuni.2013.09.002, PMID:", "ArticleIdList": ["10.1016/j.immuni.2013.09.002", "PMC3873857", "24120361"]}, {"Citation": "Braidy N., Izadi M., Sureda A., Jonaidi-Jafari N., Banki A., Nabavi S. F., et al. . (2018). Therapeutic relevance of ozone therapy in degenerative diseases: focus on diabetes and spinal pain. J. Cell. Physiol. 233, 2705\u20132714. doi: 10.1002/jcp.26044, PMID:", "ArticleIdList": ["10.1002/jcp.26044", "28594115"]}, {"Citation": "Budden K. F., Gellatly S. L., Wood D. L. A., Cooper M. A., Morrison M., Hugenholtzet P., et al. . (2017). Emerging pathogenic links between microbiota and the gut-lung axis. Nat. Rev. Microbiol. 15, 55\u201363. doi: 10.1038/nrmicro.2016.142, PMID:", "ArticleIdList": ["10.1038/nrmicro.2016.142", "27694885"]}, {"Citation": "Burke R., Chun C., Zhou G.-D., Putluri V., Putluri N., Stading R. E., et al. . (2021). Role of human NADPH quinone oxidoreductase (NQO1) in oxygen-mediated cellular injury and oxidative DNA damage in human pulmonary cells. Oxidative Med. Cell. Longev. 2021:5544600. doi: 10.1155/2021/5544600, PMID:", "ArticleIdList": ["10.1155/2021/5544600", "PMC8536466", "34691356"]}, {"Citation": "Cenci A., D\u2019Avenio G., Tavoschi L., Chiappi M., Becattini S., Del Pilar Narino M., et al. . (2014). Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms. PLoS One 9:e95183. doi: 10.1371/journal.pone.0095183, PMID:", "ArticleIdList": ["10.1371/journal.pone.0095183", "PMC4005737", "24788065"]}, {"Citation": "Cespedes-Suarez J., Martin-Serrano Y., Carballosa-Pe\u00f1a M. R., Dager-Carballosa D. R. (2018a). Response of patients with chronic hepatitis B in one year of treatment with major autohemotherapy. J. Ozone Ther. 2, 1\u20137. doi: 10.7203/jo3t.2.3.2018.11459", "ArticleIdList": ["10.7203/jo3t.2.3.2018.11459"]}, {"Citation": "Cespedes-Suarez J., Martin-Serrano Y., Carballosa-Pe\u00f1a M. R., Rosa Dager-Carballosa D. (2018b). The immune response behavior in HIV-AIDS patients treated with ozone therapy for two years. J. Ozone Ther. 2, 1\u20139. doi: 10.7203/jo3t.2.3.2018.11458", "ArticleIdList": ["10.7203/jo3t.2.3.2018.11458"]}, {"Citation": "Chen L., Glover J. N., Hogan P. G., Rao A., Harrison S. C. (1998). Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392, 42\u201348. doi: 10.1038/32100, PMID:", "ArticleIdList": ["10.1038/32100", "9510247"]}, {"Citation": "Chirumbolo S., Franzini M., Simonetti V., Valdenassi L., Ricevuti G., Bertossi D., et al. . (2021a). Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed. J. Med. Virol. 93, 2580\u20132582. doi: 10.1002/jmv.26806, PMID:", "ArticleIdList": ["10.1002/jmv.26806", "PMC8013854", "33503267"]}, {"Citation": "Chirumbolo S., Pandolfi S., Valdenassi L., Bertossi D., Franzini M. (2021b). The need for a correct oxygen-ozone autohemotherapy (O3-AHT) in patients with mild to moderate COVID-19 pneumonia. Intern. Emerg. Med. 16, 793\u2013794. doi: 10.1007/s11739-020-02592-w, PMID:", "ArticleIdList": ["10.1007/s11739-020-02592-w", "PMC7782567", "33400161"]}, {"Citation": "Chirumbolo S., Valdenassi L., Simonetti V., Bertossi D., Ricevuti G., Franzini M., et al. . (2021c). Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int. Immunopharmacol. 96, 107777\u2013107791. doi: 10.1016/j.intimp.2021.107777, PMID:", "ArticleIdList": ["10.1016/j.intimp.2021.107777", "PMC8112288", "34020394"]}, {"Citation": "Cho Y., Abu-Ali G., Tashiro H., Kasahara D. I., Brown T. A., Brand J. D., et al. . (2018). The microbiome regulates pulmonary responses to ozone in mice. Am. J. Respir. Cell Mol. Biol. 59, 346\u2013354. doi: 10.1165/rcmb.2017-0404OC, PMID:", "ArticleIdList": ["10.1165/rcmb.2017-0404OC", "PMC6189641", "29529379"]}, {"Citation": "Choi C., Finlay D. K. (2020). Diverse immunoregulatory roles of oxysterols: the oxidized cholesterol metabolites. Meta 10:384. doi: 10.3390/metabo10100384, PMID:", "ArticleIdList": ["10.3390/metabo10100384", "PMC7601797", "32998240"]}, {"Citation": "Clavo B., Santana-Rodr\u00edguez N., Llontop P., Guti\u00e9rrez D., Su\u00e1rez G., L\u00f3pez L., et al. . (2018). Ozone therapy as adjuvant for cancer treatment: is further research warranted? Evid. Based Complement. Alternat. Med. 2018:7931849. doi: 10.1155/2018/7931849, PMID:", "ArticleIdList": ["10.1155/2018/7931849", "PMC6151231", "30271455"]}, {"Citation": "Criscuolo E., Diotti R. A., Ferrarese R., Alippi C., Viscardi G., Signorelli C., et al. . (2021). Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials. Emerg. Microbes Infect. 10, 206\u2013209. doi: 10.1080/22221751.2021.1872354, PMID:", "ArticleIdList": ["10.1080/22221751.2021.1872354", "PMC7872580", "33399524"]}, {"Citation": "Dai J., Teng X., Jin S., Wu Y. (2021). The antiviral roles of hydrogen sulfide by blocking the interaction between SARS-CoV-2 and its potential cell surface receptors. Oxidative Med. Cell. Longev. 2021:7866992. doi: 10.1155/2021/7866992, PMID:", "ArticleIdList": ["10.1155/2021/7866992", "PMC8421161", "34497683"]}, {"Citation": "Dick R. A., Kwak M. W., Sutter T. S., Kensler T. W. (2001). Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem. 276, 40803\u201340810. doi: 10.1074/jbc.M105487200, PMID:", "ArticleIdList": ["10.1074/jbc.M105487200", "11524419"]}, {"Citation": "Dickson R. P., Singer B. H., Newstead M. W., Falkowski N. R., Erb-Downward J. R., Standiford T. J., et al. . (2016). Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat. Microbiol. 1, 16113\u201316119. doi: 10.1038/nmicrobiol.2016.113, PMID:", "ArticleIdList": ["10.1038/nmicrobiol.2016.113", "PMC5076472", "27670109"]}, {"Citation": "Dussault P. H., George A. D., Trullinger T. K. (1999). Peroxides as oxidative enzyme inhibitors: mechanism-based inhibition of a cysteine protease by an amino acid ozonide. Bioorg. Med. Chem. Lett. 9, 3255\u20133258. doi: 10.1016/s0960-894x(99)00563-6, PMID:", "ArticleIdList": ["10.1016/s0960-894x(99)00563-6", "10576698"]}, {"Citation": "Fern\u00e1ndez-Cuadros M. E., Albaladejo-Flor\u00edn M. J., \u00c1lava-Rabasa S., Gallego-Galiana J., P\u00e9rez-Cruz G. F., Usandizaga-Elio I., et al. . (2021). Compassionate use of rectal ozone (O3) in severe COVID-19 pneumonia: a case-control study. SN Compr. Clin. Med. 22, 1\u201315. doi: 10.1007/s42399-021-00849-9", "ArticleIdList": ["10.1007/s42399-021-00849-9", "PMC7984736", "33778374"]}, {"Citation": "Fern\u00e1ndez-Cuadros M. E., Albaladejo-Flor\u00edn M. J., \u00c1lava-Rabasa S., Usandizaga-Elio I., Martinez-Quintanilla Jimenez D., Pe\u00f1a-Lora D., et al. . (2020). Effect of rectal ozone (O3) in severe COVID-19 pneumonia: preliminary results. SN Compr. Clin. Med. 3, 1\u20139. doi: 10.1007/s42399-020-00374-1, PMID:", "ArticleIdList": ["10.1007/s42399-020-00374-1", "PMC7397966", "32838181"]}, {"Citation": "Ferreira C., Viana S. D., Reis F. (2020). Gut microbiota dysbiosis\u2013immune hyperresponse\u2013inflammation triad in coronavirus disease 2019 (COVID-19-19): impact of pharmacological and nutraceutical approaches. Microorganisms 8:1514. doi: 10.3390/microorganisms8101514", "ArticleIdList": ["10.3390/microorganisms8101514", "PMC7601735", "33019592"]}, {"Citation": "Franzini M., Valdenassi L., Ionita G. (2016). First evaluations of oxygen-ozone therapy in antibiotic-resistant infections. Ozone Ther. 1:5838. doi: 10.4081/ozone.2016.5838", "ArticleIdList": ["10.4081/ozone.2016.5838"]}, {"Citation": "Franzini M., Valdenassi L., Ricevuti G., Chirumbolo S., Depfenhart M., Bertossi D., et al. . (2020). Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int. Immunopharmacol. 88:106879. doi: 10.1016/j.intimp.2020.106879, PMID:", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Fyhrquist N., Ruokolainen L., Suomalainen A., Lehtim\u00e4ki S., Veckman V., Vendelin J., et al. . (2014). Acinetobacter species in the skin microbiota protect against allergic sensitization and inflammation. J. Allergy Clin. Immunol. 134, 1301.e11\u20131309.e11. doi: 10.1016/j.jaci.2014.07.059, PMID:", "ArticleIdList": ["10.1016/j.jaci.2014.07.059", "25262465"]}, {"Citation": "Gali\u00e8 M., Covi V., Tabaracci G., Malatesta M. (2019). The role of Nrf2 in the antioxidant cellular response to medical ozone exposure. Int. J. Mol. Sci. 20, 4009\u20134024. doi: 10.3390/ijms20164009, PMID:", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Geuking M. B., K\u00f6ller Y., Rupp S., McCoy K. D. (2014). The interplay between the gut microbiota and the immune system. Gut Microbes. 5, 411\u2013418. doi: 10.4161/gmic.29330", "ArticleIdList": ["10.4161/gmic.29330", "PMC4153781", "24922519"]}, {"Citation": "Giuliani G., Ricevuti G., Galoforo A., Franzini M. (2018). Microbiological aspects of ozone: bactericidal activity and antibiotic/antimicrobial resistance in bacterial strains treated with ozone. Ozone Ther. 3:7971. doi: 10.4081/ozone.2018.7971", "ArticleIdList": ["10.4081/ozone.2018.7971"]}, {"Citation": "Giunta R., Coppola A., Luongo C., Sammartino A., Guastafierro S., Grassia A., et al. . (2001). Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann. Hematol. 80, 745\u2013748. doi: 10.1007/s002770100377, PMID:", "ArticleIdList": ["10.1007/s002770100377", "11797116"]}, {"Citation": "Groeger A. L., Freeman B. A. (2010). Signaling actions of electrophiles: anti-inflammatory therapeutic candidates. Mol. Interv. 10, 39\u201350. doi: 10.1124/mi.10.1.7", "ArticleIdList": ["10.1124/mi.10.1.7", "PMC3139380", "20124562"]}, {"Citation": "Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., et al. . (2020). Alterations of the gut microbiota in patients with COVID-19 or H1N1 influenza. Clin. Infect. Dis. 71, 2669\u20132678. doi: 10.1093/cid/ciaa709, PMID:", "ArticleIdList": ["10.1093/cid/ciaa709", "PMC7314193", "32497191"]}, {"Citation": "Hamming I., Timens W., Bulthuis M. L. C., Lely A. T., Navis G. J., van Goor H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637. doi: 10.1002/path.1570, PMID:", "ArticleIdList": ["10.1002/path.1570", "PMC7167720", "15141377"]}, {"Citation": "He Y., Wang J., Li F., Shi Y. (2020). Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections. Front. Microbiol. 11:1302. doi: 10.3389/fmicb.2020.01302, PMID:", "ArticleIdList": ["10.3389/fmicb.2020.01302", "PMC7291771", "32582134"]}, {"Citation": "Hern\u00e1ndez A., Papadakos P. J., Torres A., Gonz\u00e1lez D. A., Vives M., Ferrando C., et al. . (2020). Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev. Esp. Anestesiol. Reanim. 67, 245\u2013252. doi: 10.1016/j.redar.2020.03.004, PMID:", "ArticleIdList": ["10.1016/j.redar.2020.03.004", "PMC7156242", "32303365"]}, {"Citation": "Hern\u00e1ndez A., Vi\u00f1als M., Pablos A., Vil\u00e1s F., Papadakos P. J., Wijeysundera D. N., et al. . (2021). Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study. Int. Immunopharmacol. 90:107261. doi: 10.1016/j.intimp.2020.107261", "ArticleIdList": ["10.1016/j.intimp.2020.107261", "PMC7833586", "33310665"]}, {"Citation": "Hilty M., Burke C., Pedro H., Cardenas P., Bush A., Bossley C., et al. . (2010). Disordered microbial communities in asthmatic airways. PLoS One 5:e8578. doi: 10.1371/journal.pone.0008578, PMID:", "ArticleIdList": ["10.1371/journal.pone.0008578", "PMC2798952", "20052417"]}, {"Citation": "Hu B., Guo H., Zhou P., Shi Z.-L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154. doi: 10.1038/s41579-020-00459-7, PMID:", "ArticleIdList": ["10.1038/s41579-020-00459-7", "PMC7537588", "33024307"]}, {"Citation": "Hu B., Zheng J., Liu Q., Yang Y., Zhang Y. (2018). The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia. J. Pain Res. 11, 1637\u20131643. doi: 10.2147/JPR.S154154, PMID:", "ArticleIdList": ["10.2147/JPR.S154154", "PMC6118245", "30214273"]}, {"Citation": "Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., et al. . (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal conserved domain. Genes Dev. 13, 76\u201386. doi: 10.1101/gad.13.1.76, PMID:", "ArticleIdList": ["10.1101/gad.13.1.76", "PMC316370", "9887101"]}, {"Citation": "Janssen-Heininger Y. M. W., Mossman B. T., Heintz N. H., Forman H. J., Kalyanaraman B., Finkel T., et al. . (2008). Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 45, 1\u201317. doi: 10.1016/j.freeradbiomed.2008.03.011", "ArticleIdList": ["10.1016/j.freeradbiomed.2008.03.011", "PMC2453533", "18423411"]}, {"Citation": "Jones M. (2012). NEWSDIG: the national early warning score development and implementation group. Clin. Med. 12, 501\u2013503. doi: 10.7861/clinmedicine.12-6-501", "ArticleIdList": ["10.7861/clinmedicine.12-6-501", "PMC5922584", "23342400"]}, {"Citation": "Kamada N., Seo S. U., Chen G. Y., N\u00fa\u00f1ez G. (2013). Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321\u2013335. doi: 10.1038/nri3430", "ArticleIdList": ["10.1038/nri3430", "23618829"]}, {"Citation": "Khadre M. A., Yousef A. E., Kim J. G. (2001). Microbiological aspects of ozone applications in food: a review. J. Food Sci. 66, 1242\u20131252. doi: 10.1111/j.1365-2621.2001.tb15196.x", "ArticleIdList": ["10.1111/j.1365-2621.2001.tb15196.x"]}, {"Citation": "Kobayashi E. H., Suzuki T., Funayama R., Nagashima T., Hayashi M., Sekine H., et al. . (2016). Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 7:11624. doi: 10.1038/ncomms1162, PMID:", "ArticleIdList": ["10.1038/ncomms1162", "PMC4879264", "27211851"]}, {"Citation": "Kolluru G. K., Shen X., Yuan S., Kevil C. G. (2017). Gasotransmitter heterocellular signaling. Antioxid. Redox Signal. 26, 936\u2013960. doi: 10.1089/ars.2016.6909, PMID:", "ArticleIdList": ["10.1089/ars.2016.6909", "PMC5455259", "28068782"]}, {"Citation": "Larini A., Bocci V. (2005). Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol. in Vitro 19, 55\u201361. doi: 10.1016/j.tiv.2004.06.007", "ArticleIdList": ["10.1016/j.tiv.2004.06.007", "15582356"]}, {"Citation": "Li Y. C., Bai W. Z., Hashikawa T. (2020a). The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 92, 552\u2013555. doi: 10.1002/jmv.25728, PMID:", "ArticleIdList": ["10.1002/jmv.25728", "PMC7228394", "32104915"]}, {"Citation": "Li W., Khor T. O., Xu C., Shen G., Jeong W. S., Yu S., et al. . (2008). Activation of Nrf2-antioxidant signaling attenuates NF kappa B-inflammatory response and elicits apotosis. Biochem. Pharmacol. 76, 1485\u20131489. doi: 10.1016/j.bcp.2008.07.017, PMID:", "ArticleIdList": ["10.1016/j.bcp.2008.07.017", "PMC2610259", "18694732"]}, {"Citation": "Li Q., Verma I. M. (2002). NF-\u03baB regulation in the immune system. Nat. Rev. Immunol. 2, 725\u2013734. doi: 10.1038/nri910", "ArticleIdList": ["10.1038/nri910", "12360211"]}, {"Citation": "Li Y., Zhou W., Yang L., You R. (2020b). Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol. Res. 157:104833. doi: 10.1016/j.phrs.2020.104833, PMID:", "ArticleIdList": ["10.1016/j.phrs.2020.104833", "PMC7194807", "32302706"]}, {"Citation": "Liang D., Shi L., Zhao J., Liu P., Sarnat J., Gao S., et al. . (2020). Urban air pollution may enhance COVID-19 case-fatality and mortality rates in the United States. Innovations 1:100047. doi: 10.1016/j.xinn.2020.100047", "ArticleIdList": ["10.1016/j.xinn.2020.100047", "PMC7505160", "32984861"]}, {"Citation": "Li\u00e9vin-Le Moal V., Servin A. L. (2006). The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 19, 315\u2013337. doi: 10.1128/CMR.19.2.315-337.2006, PMID:", "ArticleIdList": ["10.1128/CMR.19.2.315-337.2006", "PMC1471992", "16614252"]}, {"Citation": "Lindenblatt N., Bordel R., Schareck W., Menger M. D., Vollmar B. (2004). Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler. Thromb. Vasc. Biol. 24, 601\u2013606. doi: 10.1161/01.ATV.0000118279.74056.8a, PMID:", "ArticleIdList": ["10.1161/01.ATV.0000118279.74056.8a", "14739126"]}, {"Citation": "Liu W., Li H. (2020) COVID-19 Disease: ORF8 and Surface Glycoprotein Inhibit Heme Metabolism by Binding to Porphyrin 1. Available at: https://chemrxiv.org/engage/chemrxiv/article-details/60c74e1dbb8c1ab62f3db6cb"}, {"Citation": "Madu I. G., Belouzard S., Whittaker G. R. (2009). SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology 393, 265\u2013271. doi: 10.1016/j.virol.2009.07.038, PMID:", "ArticleIdList": ["10.1016/j.virol.2009.07.038", "PMC3594805", "19717178"]}, {"Citation": "Mandhare M. N., Jagdale D. M., Gaikwad P. L., Gandhi P. S., Kadam V. J. (2012). Miracle of ozone therapy as an alternative medicine. Int. J. Pharm. Chem. Biol. Sci. 2, 63\u201371."}, {"Citation": "Marantos C., Mukaro V., Ferrante J., Hii C., Ferrante A. (2008). Inhibition of the lipopolysaccharide-induced stimulation of the members of the MAPK family in human monocytes/macrophages by 4-hydroxynonenal, a product of oxidized omega-6 fatty acids. Am. J. Pathol. 173, 1057\u20131066. doi: 10.2353/ajpath.2008.071150, PMID:", "ArticleIdList": ["10.2353/ajpath.2008.071150", "PMC2543073", "18772336"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G., Schwartz A., Di Donna V. (2020). Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants 9, 389\u2013401. doi: 10.3390/antiox9050389, PMID:", "ArticleIdList": ["10.3390/antiox9050389", "PMC7278582", "32384798"]}, {"Citation": "Mittal M., Siddiqui M. R., Tran K., Reddy S. P., Malik A. B. (2014). Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20, 1126\u20131167. doi: 10.1089/ars.2012.5149", "ArticleIdList": ["10.1089/ars.2012.5149", "PMC3929010", "23991888"]}, {"Citation": "Mohan S., Gupta D. (2018). Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation. Biomed. Pharmacother. 108, 1866\u20131878. doi: 10.1016/j.biopha.2018.10.019, PMID:", "ArticleIdList": ["10.1016/j.biopha.2018.10.019", "30372892"]}, {"Citation": "M\u00f6nkem\u00fcller K., Fry L. C., Rickes R. (2020). Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19 systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19. Rev. Esp. Enferm. Dig. 112, 584\u2013585. doi: 10.17235/reed.2020.7297/202, PMID:", "ArticleIdList": ["10.17235/reed.2020.7297/202", "32579014"]}, {"Citation": "Murray B. K., Ohmine S., Tomer D. P., Jensen K. J., Johnson F. B., Kirsi J. J., et al. . (2008). Virion disruption by ozone-mediated reactive oxygen species. J. Virol. Methods 153, 74\u201377. doi: 10.1016/j.jviromet.2008.06.004, PMID:", "ArticleIdList": ["10.1016/j.jviromet.2008.06.004", "18598719"]}, {"Citation": "Musiek E. S., Gao L., Milne G. L., Han W., Everhart M. B., Wang D., et al. . (2005). Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J. Biol. Chem. 280, 35562\u201335570. doi: 10.1074/jbc.M504785200, PMID:", "ArticleIdList": ["10.1074/jbc.M504785200", "16100121"]}, {"Citation": "Mustafa A. K., Alexander P. J., Joshi D. J., Tabachnick D. R., Cross C. A., Pappas P. S., et al. . (2020). Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg. 155, 990\u2013992. doi: 10.1001/jamasurg.2020.3950, PMID:", "ArticleIdList": ["10.1001/jamasurg.2020.3950", "PMC7420824", "32780089"]}, {"Citation": "Naqvi A. A. T., Fatima K., Mohammad T., Fatima U., Singh I. K., Singh A., et al. . (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochem. Biophys. Acta 1866:165878. doi: 10.1016/j.bbadis.2020.165878, PMID:", "ArticleIdList": ["10.1016/j.bbadis.2020.165878", "PMC7293463", "32544429"]}, {"Citation": "Neri J., Lomba E., Karam A. M., De Almeda Reis S. R., Teixeira Marchionni A., Pexoto Meidrado A. (2017). Ozone therapy influence in the tissue repair process: a literature review. J. Oral Diagn. 2, 1\u20136. doi: 10.5935/2525-5711.20170032", "ArticleIdList": ["10.5935/2525-5711.20170032"]}, {"Citation": "Olbei M., Hautefort I., Modos D., Treveil A., Poletti M., Gul L. (2021). SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients. Front. Immunol. 12:629193. doi: 10.3389/fimmu.2021.629193", "ArticleIdList": ["10.3389/fimmu.2021.629193", "PMC7956943", "33732251"]}, {"Citation": "Pattaroni C., Watzenboeck M. L., Schneidegger S., Kieser S., Wong N. C., Bernasconi E., et al. . (2018). Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe 24, 857.e4\u2013865.e4. doi: 10.1016/j.chom.2018.10.019, PMID:", "ArticleIdList": ["10.1016/j.chom.2018.10.019", "30503510"]}, {"Citation": "Peng L., Mundada L., Stomel J. M., Liu J. J., Sun J., Yet S. F., et al. . (2004). Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antioxid. Redox Signal. 6, 729\u2013735. doi: 10.1089/1523086041361677, PMID:", "ArticleIdList": ["10.1089/1523086041361677", "15242554"]}, {"Citation": "Percivalle E., Clerici M., Cassaniti I., Vecchio Nepita E., Marchese P., Olivati D., et al. . (2021). SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation. J. Hosp. Infect. 110, 33\u201336. doi: 10.1016/j.jhin.2021.01.014", "ArticleIdList": ["10.1016/j.jhin.2021.01.014", "PMC7842195", "33516798"]}, {"Citation": "Pryor W. A., Gu J. T., Church D. F. (1985). Trapping free radicals formed in the reaction of ozone with simple olefins using 2,6-di-tert-butyl-4-cresol (BHT). J. Organomet. Chem. 50, 185\u2013189. doi: 10.1021/jo00202a009", "ArticleIdList": ["10.1021/jo00202a009"]}, {"Citation": "Pryor W. A., Houk K. N., Foote C. S., Fukuto J. M., Ignarro L. J., Squadrito G. L., et al. . (2006). Free radical biology and medicine: it\u2019s a gas, man! Am. J. Phys. Regul. Integr. Comp. Phys. 291, R491\u2013R511. doi: 10.1152/ajpregu.00614.2005", "ArticleIdList": ["10.1152/ajpregu.00614.2005", "16627692"]}, {"Citation": "Pryor W. A., Squadrito G. L., Friedman M. (1995). The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic. Biol. Med. 19, 935\u2013941. doi: 10.1016/0891-5849(95)02033-7, PMID:", "ArticleIdList": ["10.1016/0891-5849(95)02033-7", "8582671"]}, {"Citation": "Punjabi C. J., Laskin J. D., Pendino K. J., Goller N. L., Durham S. K., Laskin D. L. (1994). Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11, 165\u2013172. doi: 10.1165/ajrcmb.11.2.7519435", "ArticleIdList": ["10.1165/ajrcmb.11.2.7519435", "7519435"]}, {"Citation": "Ranaldi G. T., Villani E. R., Franza L., Motola G. (2020). Ozonetherapy vs. SARS-COV-2 in Gut: the Fountainhead. OSF. Available at: https://osf.io/preprints/frenxiv/e96rw"}, {"Citation": "Re L., Mart\u00ednez-S\u00e1nchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M. A., et al. . (2014). Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 742, 158\u2013162. doi: 10.1016/j.ejphar.2014.08.029, PMID:", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Rhee S. G., Bae Y. S., Lee S. R., Kwon J. (2000). Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000:pe1. doi: 10.1126/stke.2000.53.pe1, PMID:", "ArticleIdList": ["10.1126/stke.2000.53.pe1", "11752613"]}, {"Citation": "Ricevuti G., Franzini M., Valdenassi L. (2020). Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Ther. 5, 8\u201311. doi: 10.4081/ozone.2020.9014", "ArticleIdList": ["10.4081/ozone.2020.9014"]}, {"Citation": "Ristow M. (2014). Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits. Nat. Med. 20, 709\u2013711. doi: 10.1038/nm.3624", "ArticleIdList": ["10.1038/nm.3624", "24999941"]}, {"Citation": "Robba C., Battaglini D., Ball L., Patroniti N., Loconte M., Brunetti I., et al. . (2020). Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir. Physiol. Neurobiol. 279:103455. doi: 10.1016/j.resp.2020.103455, PMID:", "ArticleIdList": ["10.1016/j.resp.2020.103455", "PMC7211757", "32437877"]}, {"Citation": "Rodrigues T. S., de S\u00e1 K. S. G., Ishimoto A. Y., Becerra A., Oliveira S., Almeida L., et al. . (2021). Inflammasomes are activated in response to SARS-cov-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 218:e20201707. doi: 10.1084/JEM.20201707, PMID:", "ArticleIdList": ["10.1084/JEM.20201707", "PMC7684031", "33231615"]}, {"Citation": "Rota P. A., Oberste M. S., Monroe S. S., Nix W. A., Campagnoli R., Icenogle J. P., et al. . (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394\u20131399. doi: 10.1126/science.1085952", "ArticleIdList": ["10.1126/science.1085952", "12730500"]}, {"Citation": "Rowen R. J., Robins H. R. (2020). A plausible \u201cpenny\u201d costing effective treatment for corona virus: ozone therapy. J. Infect. Dis. Epidemiol. J. 6, 1\u20135. doi: 10.23937/2474-3658/151011", "ArticleIdList": ["10.23937/2474-3658/151011"]}, {"Citation": "Rowen R. J., Robins H., Carew K., Kamara M. M., Jalloh M. I. (2016). Rapid resolution of hemorrhagic fever (ebola) in Sierra Leone with ozone therapy. Afr. J. Infect. Dis. 10, 49\u201354. doi: 10.4314/ajid.v10i1.10", "ArticleIdList": ["10.4314/ajid.v10i1.10"]}, {"Citation": "Sagai M., Bocci V. (2011). Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med. Gas Res. 1, 29\u201347. doi: 10.1186/2045-9912-1-29, PMID:", "ArticleIdList": ["10.1186/2045-9912-1-29", "PMC3298518", "22185664"]}, {"Citation": "Santos S. F., de Oliveira H. L., Yamada E. S., Neves B. C., Pereira A., Jr. (2019). The gut and Parkinson\u2019s disease - A bidirectional pathway. Front. Neurol. 10:574. doi: 10.3389/fneur.2019.00574", "ArticleIdList": ["10.3389/fneur.2019.00574", "PMC6558190", "31214110"]}, {"Citation": "Scassellati C., Galoforo A. C., Bonvicini C. B., Esposto C., Ricevuti G. (2020). Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Res. Rev. 63:101138. doi: 10.1016/j.arr.2020.101138, PMID:", "ArticleIdList": ["10.1016/j.arr.2020.101138", "PMC7428719", "32810649"]}, {"Citation": "Schaur R. J., Siems W., Bresgen N., Eckli P. M. (2015). 4-Hydroxy-nonenal:a bioactive lipid peroxidation product. Biomol. Ther. 5, 2247\u20132337. doi: 10.3390/biom5042247", "ArticleIdList": ["10.3390/biom5042247", "PMC4693237", "26437435"]}, {"Citation": "Segal L. N., Clemente J. C., Tsay J.-C. J., Koralov S. B., Keller B. C., Wu B. G., et al. . (2016). Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 1:16031. doi: 10.1038/nmicrobiol.2016.31", "ArticleIdList": ["10.1038/nmicrobiol.2016.31", "PMC5010013", "27572644"]}, {"Citation": "Sen R., Baltimore D. (1986). Inducibility of \u03ba immunoglobulin enhancer-binding protein NF-\u03baB by a posttranslational mechanism. Cell 47, 921\u2013928. doi: 10.1016/0092-8674(86)90807-x", "ArticleIdList": ["10.1016/0092-8674(86)90807-x", "3096580"]}, {"Citation": "Shah M., Captain J., Vaidya V., Kulkarni A., Valsangkar K., Nair P. M. K., et al. . (2021). Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: a phase 1/11 randomized control trial (SEOT study). Int. Immunopharmacol. 91:107301. doi: 10.1016/j.intimp.2020.107301, PMID:", "ArticleIdList": ["10.1016/j.intimp.2020.107301", "PMC7758022", "33421928"]}, {"Citation": "Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H. (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224. doi: 10.1038/s41586-020-2179-y", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Sigrist C. J., Bridge A., Le Mercier P. (2020). A potential role for integrins in host cell entry by SARS-CoV-2. Antivir. Res. 177:104759. doi: 10.1016/j.antiviral.2020.104759", "ArticleIdList": ["10.1016/j.antiviral.2020.104759", "PMC7114098", "32130973"]}, {"Citation": "Simonetti V., Quagliariello V., Franzini M., Iaffaioli R. V., Maurea N., Valdenassi L. (2019). Ozone exerts cytoprotective and anti-inflammatory effects in cardiomyocytes and skin fibroblasts after incubation with doxorubicin. Evid. Based Complement. Alternat. Med. 2019:2169103. doi: 10.1155/2019/2169103, PMID:", "ArticleIdList": ["10.1155/2019/2169103", "PMC6885772", "31827546"]}, {"Citation": "Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M. Y., et al. . (2020). Recognizing COVID-19\u2013related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 17, 1463\u20131471. doi: 10.1016/j.hrthm.2020.05.001, PMID:", "ArticleIdList": ["10.1016/j.hrthm.2020.05.001", "PMC7199677", "32387246"]}, {"Citation": "Smith N. L., Wilson A. L., Gandhi J., Vatsia S., Khan S. A. (2017). Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med. Gas Res. 7, 212\u2013219. doi: 10.4103/2045-9912.215752", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Song X., Hu W., Yu H., Zhao L., Zhao Y., Zhao X. (2020). Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages. Cytometry A. doi: 10.1002/cyto.a.24285, Epub ahead of print", "ArticleIdList": ["10.1002/cyto.a.24285", "33280254"]}, {"Citation": "Stoker G. (1902). Ozone in chronic middle-ear deafness. Lancet 160, 1187\u20131188. doi: 10.1016/S0140-6736(01)45068-9", "ArticleIdList": ["10.1016/S0140-6736(01)45068-9"]}, {"Citation": "Stone J. R., Yang S. (2006). Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signal. 8, 243\u2013270. doi: 10.1089/ars.2006.8.243", "ArticleIdList": ["10.1089/ars.2006.8.243", "16677071"]}, {"Citation": "Sun X., Wang Y., Ji K., Liu Y., Kong Y., Nie S., et al. . (2020). NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest. Nucleic Acids Res. 48, 9109\u20139123. doi: 10.1093/nar/gkaa631", "ArticleIdList": ["10.1093/nar/gkaa631", "PMC7498319", "32729622"]}, {"Citation": "Surabhi S., Jachmann L. H., Shumba P., Burchhardt G., Hammerschmidt S., Siemens N. (2021). Hydrogen peroxide is crucial for NLRP3 inflammasome-mediated IL-1\u03b2 production and cell death in pneumococcal infections of bronchial epithelial cells. J. Innate Immun. 6, 1\u201315. doi: 10.1159/000517855, PMID:", "ArticleIdList": ["10.1159/000517855", "PMC9149442", "34515145"]}, {"Citation": "Swanson K. V., Deng M., Ting J. P. Y. (2019). The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489. doi: 10.1038/s41577-019-0165-0, PMID:", "ArticleIdList": ["10.1038/s41577-019-0165-0", "PMC7807242", "31036962"]}, {"Citation": "Travagli V., Zanardi I., Silvietti A., Bocci V. (2007). A physicochemical investigation on the effects of ozone on blood. Int. J. Biol. Macromol. 41, 504\u2013511. doi: 10.1016/j.ijbiomac.2007.06.010, PMID:", "ArticleIdList": ["10.1016/j.ijbiomac.2007.06.010", "17675149"]}, {"Citation": "Tsiambas E., Papanikolaou V., Chrysovergis A., Mastronikolis N., Ragos V., Kavantzaset N., et al. . (2020). Coronavirus in hematologic malignancies: targeting molecules beyond the angiotensin-converting enzyme 2 (ACE2) wall in COVID-19. Pathol. Oncol. Res. 26, 2823\u20132825. doi: 10.1007/s12253-020-00810-6, PMID:", "ArticleIdList": ["10.1007/s12253-020-00810-6", "PMC7182393", "32333199"]}, {"Citation": "Ueno I., Hoshino M., Miura T., Shinriki N. (1998). Ozone exposure generates free radicals in the blood samples in vitro. Detection by the ESR spin-trapping technique. Free Radic. Res. 29, 127\u2013135. doi: 10.1080/10715769800300141", "ArticleIdList": ["10.1080/10715769800300141", "9790514"]}, {"Citation": "Varesi A., Chirumbolo S., Ricevuti G. (2021). Oxygen-ozone treatment and COVID-19: antioxidants targeting endothelia lead the scenery. Intern. Emerg. Med. 22, 1\u20134. doi: 10.1007/s11739-021-02865-y", "ArticleIdList": ["10.1007/s11739-021-02865-y", "PMC8531908", "34677789"]}, {"Citation": "Villapol S. (2020). Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl. Res. 226, 57\u201369. doi: 10.1016/j.trsl.2020.08.004, PMID:", "ArticleIdList": ["10.1016/j.trsl.2020.08.004", "PMC7438210", "32827705"]}, {"Citation": "Villeneuve N. F., Sun Z., Chen W., Zhang D. D. (2009). Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle 8, 3255\u20133256. doi: 10.4161/cc.8.20.9565, PMID:", "ArticleIdList": ["10.4161/cc.8.20.9565", "PMC3918967", "19806015"]}, {"Citation": "Vo T., Paudel K., Choudhary I., Patial S., Saini Y. (2022). Ozone exposure upregulates the expression of host susceptibility protein TMPRSS2 to SARS-CoV-2. Sci. Rep. 12, 1357. doi: 10.1038/s41598-022-04906-8, PMID:", "ArticleIdList": ["10.1038/s41598-022-04906-8", "PMC8789794", "35079032"]}, {"Citation": "Voynow J. A., Hendricks-Mu\u00f1oz K. D. (2018). The gut-lung axis and pulmonary responses to ozone. Am. J. Respir. Cell Mol. Biol. 59, 281\u2013282. doi: 10.1165/rcmb.2018-0140ED", "ArticleIdList": ["10.1165/rcmb.2018-0140ED", "29723038"]}, {"Citation": "Wang W., Ye L., Ye L., Li B., Gao B., Zeng Y., et al. . (2007). Up-regulation of IL-6 and TNF-\u03b1 induced by SARS-coronavirus spike protein in murine macrophages via NF-\u03baB pathway. Virus Res. 128, 1\u20138. doi: 10.1016/j.virusres.2007.02.007, PMID:", "ArticleIdList": ["10.1016/j.virusres.2007.02.007", "PMC7114322", "17532082"]}, {"Citation": "Wang Z., Zhang A., Meng W., Wang T., Li D., Liu Z., et al. . (2018). Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol. 835, 82\u201393. doi: 10.1016/j.ejphar.2018.07.059, PMID:", "ArticleIdList": ["10.1016/j.ejphar.2018.07.059", "30075224"]}, {"Citation": "Wardyn J. D., Ponsford A. H., Sanderson C. M. (2015). Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem. Soc. Trans. 43, 621\u2013626. doi: 10.1042/BST20150014, PMID:", "ArticleIdList": ["10.1042/BST20150014", "PMC4613495", "26551702"]}, {"Citation": "Wei X., Decker J. M., Wang S., Hui H., Kappes J. C., Wu X., et al. . (2003). Antibody neutralization and escape by HIV-1. Nature 422, 307\u2013312. doi: 10.1038/nature01470", "ArticleIdList": ["10.1038/nature01470", "12646921"]}, {"Citation": "Wentworth P., McDunn J. E., Wentworth A. D., Takeuchi C., Nieva J., Jones T., et al. . (2002). Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298, 2195\u20132199. doi: 10.1126/science.1077642, PMID:", "ArticleIdList": ["10.1126/science.1077642", "12434011"]}, {"Citation": "Wenzhong L., Hualan L. (2020). COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. Available at: https://chemrxiv.org/engage/chemrxiv/article-details/6142e0d5b817b45fbb1e9b19"}, {"Citation": "Wu X., Nethery R. C., Sabath B. M., Braun D., Dominici F. (2020). Exposure to air pollution and COVID-19 mortality in the United States: a nationwide cross-sectional study. medRxiv. [Preprint]. doi: 10.1101/2020.04.05", "ArticleIdList": ["10.1101/2020.04.05", "PMC7673673", "33148655"]}, {"Citation": "Wypych T. P., Wickramasinghe L. C., Marsland B. J. (2019). The influence of the microbiome on respiratory health. Nat. Immunol. 20, 1279\u20131290. doi: 10.1038/s41590-019-0451-9", "ArticleIdList": ["10.1038/s41590-019-0451-9", "31501577"]}, {"Citation": "Yang Y. M., Fang F., Li X., Yu L., Wang Z. C. (2017). TRAIL overexpression co-regulated by Egr1 and HRE enhances radiosensitivity of hypoxic A549 cells depending on its apoptosis inducing role. Oncol. Rep. 37, 533\u2013539. doi: 10.3892/or.2016.5271", "ArticleIdList": ["10.3892/or.2016.5271", "27878298"]}, {"Citation": "Yano H., Nakano R., Suzuki Y., Nakano A., Kasahara K., Hosoi H. (2020). Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment. J. Hosp. Infect. 106, 837\u2013838. doi: 10.1016/j.jhin.2020.10.004", "ArticleIdList": ["10.1016/j.jhin.2020.10.004", "PMC7547371", "33049366"]}, {"Citation": "Yu G., Bai Z., Chen Z., Chen H., Wang G., Wang G., et al. . (2017). The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease. Int. Immunopharmacol. 43, 203\u2013209. doi: 10.1016/j.intimp.2016.12.022", "ArticleIdList": ["10.1016/j.intimp.2016.12.022", "28038382"]}, {"Citation": "Zeng J., Dou J., Gao L., Xiang Y., Huang J., Ding S., et al. . (2020). Topical ozone therapy restores microbiome diversity in atopic dermatitis. Int. Immunopharmacol. 80:106191. doi: 10.1016/j.intimp.2020.106191, PMID:", "ArticleIdList": ["10.1016/j.intimp.2020.106191", "31986325"]}, {"Citation": "Zu S., Deng Y.-Q., Zhou C., Li J., Li L., Chen Q., et al. . (2020). 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 30, 1043\u20131045. doi: 10.1038/s41422-020-00398-1, PMID:", "ArticleIdList": ["10.1038/s41422-020-00398-1", "PMC7431750", "32811977"]}, {"Citation": "Zuo T., Zhang F., Lui G. C. Y., Yeoh Y. K., Li A. Y. L., Zhan H., et al. . (2020). Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159, 944.e8\u2013955.e8. doi: 10.1053/j.gastro.2020.05.048", "ArticleIdList": ["10.1053/j.gastro.2020.05.048", "PMC7237927", "32442562"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "8"}, {"Year": "2022", "Month": "3", "Day": "7"}, {"Year": "2022", "Month": "5", "Day": "9", "Hour": "4", "Minute": "32"}, {"Year": "2022", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35531273", "PMC9069003", "10.3389/fmicb.2022.871645"]}}], "PubmedBookArticle": []}